Trial intelligence / Profile preview

Vitamin K supplementation and bone health in adolescents and adults with cystic fibrosis

2006-000945-20Phase 3Completed

Sponsor
Barts Health NHS Trust
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of menadiol in cystic fibrosis (CF) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Change in ratio of undercarboxylated osteocalcin to total osteocalcin. Started Sep 2006; status: completed.

02

Drugs

menadiol
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on 2006-000945-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000945-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call